These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26027226)

  • 1. [Anaesthesia and intensive care during intraoperative intraperitoneal hyperthermic chemotherapy in patients with gastric cancer (literature review and own clinical experience)].
    Khoronenko VE; Shemetova MM; Drozhzhina OV; Khomyakov VM; Sobolev DD
    Anesteziol Reanimatol; 2015; 60(1):50-4. PubMed ID: 26027226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer.
    Samel S; Singal A; Becker H; Post S
    Eur J Surg Oncol; 2000 Apr; 26(3):222-6. PubMed ID: 10753533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer].
    Wei G; Fang GE; Bi JW; Shen XJ; Nie MM; Xue XC; Hua JD
    Ai Zheng; 2005 Apr; 24(4):478-82. PubMed ID: 15820074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer.
    de Bree E; Witkamp AJ; Zoetmulder FA
    Eur J Surg Oncol; 2000 Sep; 26(6):630-2. PubMed ID: 11034822
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
    Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].
    Mátrai Z; Péley G; Kovács T; Rényi VF; Szívós E; Szabó E; Vereczkey I; Török K; Köves I
    Orv Hetil; 2006 Jan; 147(4):147-58. PubMed ID: 16515023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials.
    Mi DH; Li Z; Yang KH; Cao N; Lethaby A; Tian JH; Santesso N; Ma B; Chen YL; Liu YL
    Int J Hyperthermia; 2013; 29(2):156-67. PubMed ID: 23418917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
    Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
    In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
    Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
    Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
    Huang O; Lu X; Xu X; Shi Y
    Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
    Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
    Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients.
    Costa WL; Coimbra FJ; Ribeiro HS; Diniz AL; de Godoy AL; Begnami M; Silva MJ; Fanelli MF; Mello CA
    World J Surg Oncol; 2012 Sep; 10():195. PubMed ID: 22992263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer].
    Zhang GY; Chen XC; Pan K; Xia LG; Zuo M; Zheng T
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):362-4. PubMed ID: 17659464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal arrhythmia following intraoperative continuous hyperthermic peritoneal perfusion chemotherapy.
    Chung NC; Liu YC; Ye XD; Wang YM; Kuo MC; Liu K
    Acta Anaesthesiol Sin; 2003 Dec; 41(4):201-4. PubMed ID: 14768518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.